Last Updated : February 11, 2005
Details
FilesGeneric Name:
Insulin glargine (rDNA origin)
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus, Type 1 & 2
Manufacturer:
Aventis Pharma Inc.
Brand Name:
Lantus
Project Line:
Reimbursement Review
Project Number:
SR0033-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes mellitus, Type 1 & 2
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list
Files
Last Updated : February 11, 2005